De Maré, A.; Verhulst, A.; Cavalier, E.; Delanaye, P.; Behets, G.J.; Meijers, B.; Kuypers, D.; D’Haese, P.C.; Evenepoel, P.
Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease. J. Clin. Med. 2019, 8, 2027.
https://doi.org/10.3390/jcm8122027
AMA Style
De Maré A, Verhulst A, Cavalier E, Delanaye P, Behets GJ, Meijers B, Kuypers D, D’Haese PC, Evenepoel P.
Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease. Journal of Clinical Medicine. 2019; 8(12):2027.
https://doi.org/10.3390/jcm8122027
Chicago/Turabian Style
De Maré, Annelies, Anja Verhulst, Etienne Cavalier, Pierre Delanaye, Geert J. Behets, Bjorn Meijers, Dirk Kuypers, Patrick C. D’Haese, and Pieter Evenepoel.
2019. "Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease" Journal of Clinical Medicine 8, no. 12: 2027.
https://doi.org/10.3390/jcm8122027
APA Style
De Maré, A., Verhulst, A., Cavalier, E., Delanaye, P., Behets, G. J., Meijers, B., Kuypers, D., D’Haese, P. C., & Evenepoel, P.
(2019). Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease. Journal of Clinical Medicine, 8(12), 2027.
https://doi.org/10.3390/jcm8122027